SCHEMBL14198060

SCHEMBL14198060

CC(C)=Cc1cc(C(C)(C)C)ccc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
ALDH1A1 P00352 4/20 0.55
HPGD P15428 1/20 0.55
ALOX15 P16050 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
GAA P10253 3/20 0.50
PKM P14618 2/20 0.50
RECQL P46063 1/20 0.50
KDM4E B2RXH2 2/20 0.45
CYP2D6 P10635 3/20 0.43
LMNA P02545 2/20 0.40
TYR P14679 1/20 0.40
SIRT1 Q96EB6 1/20 0.40
ESR1 P03372 1/20 0.39
NPC1 O15118 1/20 0.39
HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL332380 0.78 MAPT (0.62) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL22096860 0.78 MAPT (0.62) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL14612751 0.78 MAPT (0.62) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL11417093 0.77 MAPT (0.61) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL10857157 0.77 ALDH1A1 (0.42) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL11521420 0.76 MAPT (1.00) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL11521418 0.76 MAPT (1.00) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL16472974 0.76 MAPT (1.00) MAPTSMN1; SMN2ALDH1A1HPGDALOX15
SCHEMBL28909818 0.75 EGFR (0.49) MAPTALDH1A1HPGDALOX15HSD17B10
SCHEMBL27958960 0.75 MAPT (0.54) MAPTSMN1; SMN2ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096894-A1 Anti-Bacterial Compounds ASTON UNIVERSITY (GB) 2008-04-24 US disclosed
US-20080096894-A1 Anti-Bacterial Compounds ASTON UNIVERSITY (GB) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096894-A1 Anti-Bacterial Compounds MRPL21, PGLS, FOSB MAPT 2813/4885SMN1; SMN2 4485/4885ALDH1A1 3322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.